Interphex Tokyo 2025 x KACTUS

By Hannah Flaherty

June 16, 2025

KACTUS is excited to announce our participation in INTERPHEX Week Tokyo 2025—Japan’s largest exhibition for pharmaceutical and biopharmaceutical manufacturing technologies. Taking place from July 9–11, 2025, at Tokyo Big Sight, this premier event brings together leading professionals across drug discovery, manufacturing, quality control, and regenerative medicine.

What is Interphex Week Tokyo?

INTERPHEX Week Tokyo is a premier annual exhibition that unites scientists, engineers, and business leaders from the pharmaceutical and biotechnology industries to explore the latest technologies in drug development and manufacturing. The event spans key areas such as pharmaceutical ingredients, biopharmaceutical production, regenerative medicine, quality control, and digital transformation. With a strong focus on innovation and practical solutions, INTERPHEX Week Tokyo serves as a comprehensive platform for advancing pharmaceutical manufacturing, automation, and compliance across Asia and beyond.

Event Overview 

Venue: Tokyo Big Sight, 3 Chome-11-1 Ariake, Koto City, Tokyo 135-0063, Japan

Dates: July 9th to 11th

  • Conference Day 1: Wednesday, July 9, 2025 – 10:00 AM to 5:00 PM

  • Conference Day 2: Thursday, July 10, 2025 – 10:00 AM to 5:00 PM

  • Conference Day 3: Friday, July 11, 2025 – 10:00 AM to 5:00 PM

Booth #E6-36

Event Schedule 

INTERPHEX Week Tokyo showcases the latest innovations in pharmaceutical and biopharmaceutical manufacturing. Across three days, the event features expert-led sessions, technical seminars, and networking opportunities focused on drug development, automation, and next-gen therapies. Explore the full agenda for what’s ahead.

Day 1: Wednesday, July 9, 2025

  • Registration, Coffee, and Exhibit/Poster Viewing from 9:30 AM to 10:00 AM
    Chairperson’s Remarks from 10:00 AM to 10:05 AM

  • Keynote Presentations from 10:05 AM to 11:00 AM
    (e.g., “Stable Supply of Pharmaceuticals” by Ministry of Health, Labour and Welfare)

  • Networking Refreshment Break from 11:00 AM to 11:15 AM
    Morning Scientific Presentations from 11:15 AM to 12:00 PM

  • Scientific Briefings from 12:30 PM to 1:15 PM
    Registration, Coffee, and Exhibit/Poster Viewing from 1:15 PM to 2:00 PM

  • Scientific Briefings from 2:00 PM to 3:15 PM

  • Afternoon Track Sessions from 3:30 PM to 4:30 PM

  • Networking Cocktail Reception and Exhibit/Poster Viewing from 4:30 PM to 5:00 PM

Day 2: Thursday, July 10, 2025

  • Registration, Coffee, and Exhibit/Poster Viewing from 9:30 AM to 10:00 AM

  • Chairperson’s Remarks from 10:00 AM to 10:05 AM

  • Keynote Presentations from 10:05 AM to 11:00 AM
    (e.g., “GMP Compliance and Governance” by MHLW)

  • Networking Refreshment Break from 11:00 AM to 11:30 AM

  • Morning Scientific Presentations from 11:30 AM to 12:30 PM
    Scientific Briefings from 12:45 PM to 1:30 PM

  • Registration, Coffee, and Exhibit/Poster Viewing from 1:30 PM to 2:00 PM

  • Scientific Briefings from 2:00 PM to 3:15 PM

  • Afternoon Track Sessions from 3:30 PM to 4:30 PM

  • Networking Cocktail Reception and Exhibit/Poster Viewing from 4:30 PM to 5:00 PM

Day 3: Friday, July 11, 2025

  • Registration, Coffee, and Exhibit/Poster Viewing from 9:30 AM to 10:00 AM

  • Chairperson’s Remarks from 10:00 AM to 10:05 AM

  • Keynote Presentations from 10:05 AM to 11:00 AM
    (e.g., Chugai, Kyowa Kirin, and Astellas keynotes on future therapies)

  • Networking Refreshment Break from 11:00 AM to 11:30 AM

  • Morning Scientific Presentations from 11:30 AM to 12:30 PM

  • Scientific Briefings from 12:45 PM to 1:30 PM
    Registration, Coffee, and Exhibit/Poster Viewing from 1:30 PM to 2:00 PM

  • Scientific Briefings from 2:00 PM to 3:15 PM

  • Afternoon Track Sessions from 3:30 PM to 4:30 PM

  • Networking Cocktail Reception and Exhibit/Poster Viewing from 4:30 PM to 5:00 PM

About KACTUS

KACTUS specializes in the development and production of high-quality, bioactive recombinant proteins and enzymes that support innovation across antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. With a catalog of over 2,500 recombinant proteins spanning diverse targets, species, tags, and formats, we are committed to meeting the evolving needs of scientists in translational research. Our focus on rigorous quality control and reliable supply ensures the consistency and performance that today’s therapeutic development demands.

Featured Products 

MHC Monomers & Tetramers

Transmembrane Proteins 

Recombinant Proteins

 

Latest Posts

BAFF and APRIL: Key Targets in Autoimmune Diseases and a Review of Dual- and Single-Target Inhibitors
Rewriting Life's Code: CRISPR Precisely Edits Blood Disorder Defects
A New Era in Targeted Therapies: Ichnos Glenmark Innovation and AbbVie Blaze a Trail with Tri-specific Antibodies
1 2 3 5